Cargando...
β2-Agonists and the Incidence of Parkinson Disease
A recent study found a decreased risk of Parkinson disease (PD) associated with the β2 adrenergic agonist (β2-agonist) salbutamol. However, other mechanisms might explain this apparent association. Using the UK Clinical Practice Research Datalink, we formed a cohort of 2,430,884 patients aged 50 yea...
Guardado en:
| Publicado en: | Am J Epidemiol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7407600/ https://ncbi.nlm.nih.gov/pubmed/32016345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwaa012 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|